Dynamic Technology Lab’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History

Dynamic Technology Lab’s Portfolio CNCE Stock Details CNCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-10,536	Closed	-$33K	–	1655
2021 Q4	$33K	Buy	+10,536	New	+$35.1K	﹤0.01%	1076
2018 Q3	–	Sell	-10,574	Closed	-$178K	–	1440
2018 Q2	$178K	Buy	+10,574	New	+$205K	0.03%	867
2018 Q1	–	Sell	-63,974	Closed	-$1.66M	–	1462
2017 Q4	$1.66M	Buy	+63,974	New	+$1.29M	0.29%	24
2017 Q2	–	Sell	-21,217	Closed	-$362K	–	1406
2017 Q1	$362K	Buy	+21,217	New	+$254K	0.09%	466
2016 Q2	–	Sell	-12,466	Closed	-$170K	–	1232
2016 Q1	$170K	Buy	+12,466	New	+$179K	0.05%	775
2015 Q4	–	Sell	-11,312	Closed	-$212K	–	1192
2015 Q3	$212K	Buy	+11,312	New	+$192K	0.07%	618

Other funds holding CNCE

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

ISL

Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Dynamic Technology Lab's CNCE Position: Q1 2022 in Review

Dynamic Technology Lab sold out of Concert Pharmaceuticals, Inc. (CNCE) in Q1 2022, closing a stake of 10,536 shares — an estimated $33K sold.

Dynamic Technology Lab first reported a position in CNCE in Q3 2015 and held it in 6 quarters. The position peaked at $1.66M in Q4 2017. 53 funds tracked by Wall St. Rank hold CNCE as of Q1 2022.

Dynamic Technology Lab reported no remaining Concert Pharmaceuticals, Inc. position as of Q1 2022 after selling out during the quarter.
Dynamic Technology Lab sold 10,536 Concert Pharmaceuticals, Inc. shares in Q1 2022, an estimated $33K.
Dynamic Technology Lab first reported a position in Concert Pharmaceuticals, Inc. in Q3 2015 and held it in 6 quarters.
Dynamic Technology Lab's Concert Pharmaceuticals, Inc. position peaked at $1.66M in Q4 2017.
53 funds tracked by Wall St. Rank held Concert Pharmaceuticals, Inc. as of Q1 2022.

Based on Dynamic Technology Lab's 13F filing for Q1 2022, filed 16 May 2022.